"Antidepressive Agents" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Mood-stimulating drugs used primarily in the treatment of affective disorders and related conditions. Several MONOAMINE OXIDASE INHIBITORS are useful as antidepressants apparently as a long-term consequence of their modulation of catecholamine levels. The tricyclic compounds useful as antidepressive agents (ANTIDEPRESSIVE AGENTS, TRICYCLIC) also appear to act through brain catecholamine systems. A third group (ANTIDEPRESSIVE AGENTS, SECOND-GENERATION) is a diverse group of drugs including some that act specifically on serotonergic systems.
Descriptor ID |
D000928
|
MeSH Number(s) |
D27.505.954.427.700.122
|
Concept/Terms |
Antidepressive Agents- Antidepressive Agents
- Agents, Antidepressive
- Antidepressant Drugs
- Drugs, Antidepressant
- Antidepressants
|
Below are MeSH descriptors whose meaning is more general than "Antidepressive Agents".
Below are MeSH descriptors whose meaning is more specific than "Antidepressive Agents".
This graph shows the total number of publications written about "Antidepressive Agents" by people in this website by year, and whether "Antidepressive Agents" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1994 | 2 | 1 | 3 |
1995 | 0 | 2 | 2 |
1996 | 2 | 1 | 3 |
1997 | 1 | 0 | 1 |
1998 | 2 | 3 | 5 |
1999 | 0 | 5 | 5 |
2000 | 2 | 1 | 3 |
2001 | 1 | 2 | 3 |
2002 | 4 | 1 | 5 |
2003 | 5 | 2 | 7 |
2004 | 4 | 3 | 7 |
2005 | 2 | 3 | 5 |
2006 | 5 | 2 | 7 |
2007 | 4 | 3 | 7 |
2008 | 1 | 3 | 4 |
2009 | 4 | 3 | 7 |
2010 | 4 | 1 | 5 |
2011 | 4 | 1 | 5 |
2012 | 4 | 5 | 9 |
2013 | 4 | 3 | 7 |
2014 | 2 | 2 | 4 |
2015 | 6 | 5 | 11 |
2016 | 4 | 4 | 8 |
2017 | 1 | 3 | 4 |
2018 | 4 | 3 | 7 |
2019 | 1 | 2 | 3 |
2020 | 3 | 3 | 6 |
2021 | 0 | 2 | 2 |
2022 | 1 | 2 | 3 |
2023 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Antidepressive Agents" by people in Profiles.
-
EEG synchronized left prefrontal transcranial magnetic stimulation (TMS) for treatment resistant depression is feasible and produces an entrainment dependent clinical response: A randomized controlled double blind clinical trial. Brain Stimul. 2023 Nov-Dec; 16(6):1753-1763.
-
The role of exercise in the treatment of depression: biological underpinnings and clinical outcomes. Mol Psychiatry. 2023 01; 28(1):298-328.
-
Effect of Pharmacogenomic Testing for Drug-Gene Interactions on Medication Selection and Remission of Symptoms in Major Depressive Disorder: The PRIME Care Randomized Clinical Trial. JAMA. 2022 07 12; 328(2):151-161.
-
Shaping plasticity with non-invasive brain stimulation in the treatment of psychiatric disorders: Present and future. Handb Clin Neurol. 2022; 184:497-507.
-
The evidence is in: Repetitive transcranial magnetic stimulation is an effective, safe and well-tolerated treatment for patients with major depressive disorder. Aust N Z J Psychiatry. 2022 07; 56(7):745-751.
-
Integrating the monoamine and cytokine hypotheses of depression: Is histamine the missing link? Eur J Neurosci. 2022 05; 55(9-10):2895-2911.
-
Sex Differences in the Inflammatory Consequences of Stress: Implications for Pharmacotherapy. J Pharmacol Exp Ther. 2020 10; 375(1):161-174.
-
Constant-severe pain in chronic pancreatitis is associated with genetic loci for major depression in the NAPS2 cohort. J Gastroenterol. 2020 Oct; 55(10):1000-1009.
-
Effects of ketamine and other rapidly acting antidepressants on hippocampal excitatory and inhibitory transmission. Adv Pharmacol. 2020; 89:3-41.
-
Cortisol awakening response in PTSD treatment: Predictor or mechanism of change. Psychoneuroendocrinology. 2020 08; 118:104714.